MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.620
-0.010 (-0.61%)
Mar 28, 2025, 4:00 PM EST - Market closed
MAIA Biotechnology Employees
MAIA Biotechnology had 13 employees as of December 31, 2023. The number of employees decreased by 5 or -27.78% compared to the previous year.
Employees
13
Change (1Y)
-5
Growth (1Y)
-27.78%
Revenue / Employee
n/a
Profits / Employee
-$1,788,820
Market Cap
47.93M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13 | -5 | -27.78% |
Dec 31, 2022 | 18 | 9 | 100.00% |
Dec 31, 2021 | 9 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MAIA News
- 5 days ago - MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025 - Business Wire
- 10 days ago - MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug - Business Wire
- 11 days ago - MAIA Biotechnology Receives USAN Council Approval for “Ateganosine” as Nonproprietary Name for Anticancer Agent THIO - Business Wire
- 4 weeks ago - MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients - Business Wire
- 4 weeks ago - MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer - Business Wire
- 4 weeks ago - MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million - Business Wire
- 5 weeks ago - MAIA Biotechnology Announces Private Placement of $2,715,000 - Business Wire
- 7 weeks ago - MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer - Business Wire